Page last updated: 2024-11-02

pentoxifylline and Periodontal Diseases

pentoxifylline has been researched along with Periodontal Diseases in 1 studies

Periodontal Diseases: Pathological processes involving the PERIODONTIUM including the gum (GINGIVA), the alveolar bone (ALVEOLAR PROCESS), the DENTAL CEMENTUM, and the PERIODONTAL LIGAMENT.

Research Excerpts

ExcerptRelevanceReference
"Concomitantly to AIA, mice presented alveolar bone loss, and recruitment of osteoclasts and neutrophils to periodontal tissues."1.39Preventive and therapeutic anti-TNF-α therapy with pentoxifylline decreases arthritis and the associated periodontal co-morbidity in mice. ( Bessoni, RL; Costa, VV; Queiroz-Junior, CM; Silva, TA; Souza, DG; Teixeira, MM, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Queiroz-Junior, CM1
Bessoni, RL1
Costa, VV1
Souza, DG1
Teixeira, MM1
Silva, TA1

Other Studies

1 other study available for pentoxifylline and Periodontal Diseases

ArticleYear
Preventive and therapeutic anti-TNF-α therapy with pentoxifylline decreases arthritis and the associated periodontal co-morbidity in mice.
    Life sciences, 2013, Sep-17, Volume: 93, Issue:9-11

    Topics: Alveolar Bone Loss; Animals; Antigens; Arthritis, Experimental; Arthritis, Rheumatoid; C-Reactive Pr

2013